Theravance Biopharma Inc (0TB) — Cash Flow Reinvestment Rate
Latest as of June 2025:
0.17x
Theravance Biopharma Inc (0TB) has a Cash Flow Reinvestment Rate of 0.17x as of June 2025, reinvesting €36.22 Million (capex €0.00 plus investments €-36.22 Million) from operating cash flow of €208.07 Million. Check 0TB cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.17x
(Capex + Investments) / Operating CF
Total Reinvested
€36.22 Million
Capex + Investments
Operating Cash Flow
€208.07 Million
EUR
Capital Expenditures
€0.00
EUR
Annual Cash Flow Reinvestment Rate for Theravance Biopharma Inc (None–None)
Year-by-year capital reinvestment analysis for Theravance Biopharma Inc. For live market cap and broader valuation context, see Theravance Biopharma Inc (0TB) total market value.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow